210 related articles for article (PubMed ID: 24261474)
21. Contributions of prescribed and non-prescribed opioids to opioid related deaths: population based cohort study in Ontario, Canada.
Gomes T; Khuu W; Martins D; Tadrous M; Mamdani MM; Paterson JM; Juurlink DN
BMJ; 2018 Aug; 362():k3207. PubMed ID: 30158106
[TBL] [Abstract][Full Text] [Related]
22. Trends and regional variation in opioid overdose mortality among Veterans Health Administration patients, fiscal year 2001 to 2009.
Bohnert AS; Ilgen MA; Trafton JA; Kerns RD; Eisenberg A; Ganoczy D; Blow FC
Clin J Pain; 2014 Jul; 30(7):605-12. PubMed ID: 24281278
[TBL] [Abstract][Full Text] [Related]
23. Using poison center exposure calls to predict prescription opioid abuse and misuse-related emergency department visits.
Davis JM; Severtson SG; Bucher-Bartelson B; Dart RC
Pharmacoepidemiol Drug Saf; 2014 Jan; 23(1):18-25. PubMed ID: 24130046
[TBL] [Abstract][Full Text] [Related]
24. A history of being prescribed controlled substances and risk of drug overdose death.
Paulozzi LJ; Kilbourne EM; Shah NG; Nolte KB; Desai HA; Landen MG; Harvey W; Loring LD
Pain Med; 2012 Jan; 13(1):87-95. PubMed ID: 22026451
[TBL] [Abstract][Full Text] [Related]
25. Trends in opioid analgesic abuse and mortality in the United States.
Dart RC; Surratt HL; Cicero TJ; Parrino MW; Severtson SG; Bucher-Bartelson B; Green JL
N Engl J Med; 2015 Jan; 372(3):241-8. PubMed ID: 25587948
[TBL] [Abstract][Full Text] [Related]
26. Trends in dispensing of individual prescription opioid formulations, Canada 2005-2020.
Jones W; Kaoser R; Rudoler D; Fischer B
J Pharm Policy Pract; 2022 Mar; 15(1):27. PubMed ID: 35351208
[TBL] [Abstract][Full Text] [Related]
27. FDA confronts opioid addiction and overdose deaths.
Furlow B
Lancet Oncol; 2016 Mar; 17(3):e95. PubMed ID: 26877160
[No Abstract] [Full Text] [Related]
28. Trends in opioid consumption in the Nordic countries 2002-2006.
Hamunen K; Paakkari P; Kalso E
Eur J Pain; 2009 Oct; 13(9):954-62. PubMed ID: 19091608
[TBL] [Abstract][Full Text] [Related]
29. Fentanyl use among street drug users in Toronto, Canada: behavioural dynamics and public health implications.
Firestone M; Goldman B; Fischer B
Int J Drug Policy; 2009 Jan; 20(1):90-2. PubMed ID: 18508256
[TBL] [Abstract][Full Text] [Related]
30. Understanding the Implications of a Shifting Opioid Landscape in Ontario.
Gomes T; Juurlink DN
Healthc Q; 2019 Oct; 22(3):6-11. PubMed ID: 31845850
[TBL] [Abstract][Full Text] [Related]
31. Comparative Rates of Mortality and Serious Adverse Effects Among Commonly Prescribed Opioid Analgesics.
Murphy DL; Lebin JA; Severtson SG; Olsen HA; Dasgupta N; Dart RC
Drug Saf; 2018 Aug; 41(8):787-795. PubMed ID: 29582394
[TBL] [Abstract][Full Text] [Related]
32. Patterns, trends and determinants of medical opioid utilization in Canada 2005-2020: characterizing an era of intensive rise and fall.
Jones W; Kaoser R; Fischer B
Subst Abuse Treat Prev Policy; 2021 Sep; 16(1):65. PubMed ID: 34521418
[TBL] [Abstract][Full Text] [Related]
33. Overdose Risk in Young Children of Women Prescribed Opioids.
Finkelstein Y; Macdonald EM; Gonzalez A; Sivilotti MLA; Mamdani MM; Juurlink DN;
Pediatrics; 2017 Mar; 139(3):. PubMed ID: 28219963
[TBL] [Abstract][Full Text] [Related]
34. Prescription opioid analgesic use in France: Trends and impact on morbidity-mortality.
Chenaf C; Kaboré JL; Delorme J; Pereira B; Mulliez A; Zenut M; Delage N; Ardid D; Eschalier A; Authier N
Eur J Pain; 2019 Jan; 23(1):124-134. PubMed ID: 30051548
[TBL] [Abstract][Full Text] [Related]
35. High-risk use by patients prescribed opioids for pain and its role in overdose deaths.
Gwira Baumblatt JA; Wiedeman C; Dunn JR; Schaffner W; Paulozzi LJ; Jones TF
JAMA Intern Med; 2014 May; 174(5):796-801. PubMed ID: 24589873
[TBL] [Abstract][Full Text] [Related]
36. Non-medical prescription opioid use, prescription opioid-related harms and public health in Canada: an update 5 years later.
Fischer B; Gooch J; Goldman B; Kurdyak P; Rehm J
Can J Public Health; 2014 Apr; 105(2):e146-9. PubMed ID: 24886852
[TBL] [Abstract][Full Text] [Related]
37. The association between prescription opioid dispensing and opioid-related morbidity and mortality in Ontario, Canada: an ecological study of public health units.
Ladha KS; Wijeysundera DN; Wunsch H; Clarke H; Diep C; Gomes T
Drug Alcohol Depend; 2021 Oct; 227():108989. PubMed ID: 34482045
[TBL] [Abstract][Full Text] [Related]
38. Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004.
Cicero TJ; Inciardi JA; Muñoz A
J Pain; 2005 Oct; 6(10):662-72. PubMed ID: 16202959
[TBL] [Abstract][Full Text] [Related]
39. Correlations between Changes in Medical Opioid Dispensing and Contributions of Fentanyl to Opioid-Related Overdose Fatalities: Exploratory Analyses from Canada.
Jones W; Lee MA; Kaoser R; Fischer B
Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34299958
[TBL] [Abstract][Full Text] [Related]
40. Trends and sex differences in prescription opioid deaths in British Columbia, Canada.
Gladstone EJ; Smolina K; Morgan SG
Inj Prev; 2016 Aug; 22(4):288-90. PubMed ID: 26195562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
